BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Treatment
59 results:

  • 1. Rational design of NIR-II molecule-engineered nanoplatform for preoperative downstaging and imaging-guided surgery of orthotopic hepatic tumor.
    Pan Q; Li K; Kang X; Li K; Cheng Z; Wang Y; Xu Y; Li L; Li N; Wu G; Yang S; Qi S; Chen G; Tan X; Zhan Y; Tang L; Zhan W; Yang Q
    J Nanobiotechnology; 2023 Dec; 21(1):489. PubMed ID: 38111035
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ADAMTS12 is a stromal modulator in chronic liver disease.
    Dekky B; Azar F; Bonnier D; Monseur C; Kalebić C; Arpigny E; Colige A; Legagneux V; Théret N
    FASEB J; 2023 Nov; 37(11):e23237. PubMed ID: 37819632
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
    Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Intracellular Formation of Hemicyanine Nanoparticle Enhances Tumor-Targeting Photoacoustic Imaging and Photothermal Therapy.
    Zhang L; Wang M; Wu F; Liu L; Ren X; Hai Z
    Adv Healthc Mater; 2023 Apr; 12(9):e2202676. PubMed ID: 36535275
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. pai/MRI Visualization of Tumor Derived Cellular Microvesicles with Endogenous Biopolymer Nanoparticles Modification.
    Lv S; Sun J; Guo C; Qin Y; Zhang R
    Int J Nanomedicine; 2022; 17():2883-2890. PubMed ID: 35795080
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Integrated transcriptome and in vitro analysis revealed anti-proliferative effect of sodium perborate on hepatocellular carcinoma cells.
    Omeroglu Ulu Z; Bolat ZB; Sahin F
    J Trace Elem Med Biol; 2022 Sep; 73():127011. PubMed ID: 35716648
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A multifunctional targeted nanoprobe with high NIR-II pai/MRI performance for precise theranostics of orthotopic early-stage hepatocellular carcinoma.
    He L; Zhang Y; Chen J; Liu G; Zhu J; Li X; Li D; Yang Y; Lee CS; Shi J; Yin C; Lai P; Wang L; Fang C
    J Mater Chem B; 2021 Nov; 9(42):8779-8792. PubMed ID: 34635903
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. cancer‑associated fibroblast‑induced M2‑polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor‑1 pathway.
    Chen S; Morine Y; Tokuda K; Yamada S; Saito Y; Nishi M; Ikemoto T; Shimada M
    Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195849
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
    Zhang C; Li L; Hou S; Shi Z; Xu W; Wang Q; He Y; Gong Y; Fang Z; Yang Y
    J Ethnopharmacol; 2021 Oct; 279():114350. PubMed ID: 34157326
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Identification of targets of JS-K against HBV-positive human hepatocellular carcinoma HepG2.2.15 cells with iTRAQ proteomics.
    Liu Z; Xu Y; Zhang W; Gao X; Luo G; Song H; Liu J; Wang H
    Sci Rep; 2021 May; 11(1):10381. PubMed ID: 34001947
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Population-based matching comparison between radiofrequency ablation and percutaneous ethanol or acetic acid injection for hepatocellular carcinoma.
    Chang YJ; Chen LJ; Chang YJ; Chen PD
    Eur J Surg Oncol; 2020 Sep; 46(9):1703-1710. PubMed ID: 32475629
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Multimodality Molecular Imaging-Guided Tumor Border Delineation and Photothermal Therapy Analysis Based on Graphene Oxide-Conjugated Gold Nanoparticles Chelated with Gd.
    Ma X; Jin Y; Wang Y; Zhang S; Peng D; Yang X; Wei S; Chai W; Li X; Tian J
    Contrast Media Mol Imaging; 2018; 2018():9321862. PubMed ID: 29853812
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. STAT3 aggravates TGF-β1-induced hepatic epithelial-to-mesenchymal transition and migration.
    Wang B; Liu T; Wu JC; Luo SZ; Chen R; Lu LG; Xu MY
    Biomed Pharmacother; 2018 Feb; 98():214-221. PubMed ID: 29268242
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Selumetinib Inhibits Melanoma Metastasis to Mouse liver
    Ryu SH; Heo SH; Park EY; Choi KC; Ryu JW; Lee SH; Lee SW
    Anticancer Res; 2017 Feb; 37(2):607-614. PubMed ID: 28179307
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
    Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
    J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma.
    Weis S; Franke A; Berg T; Mössner J; Fleig WE; Schoppmeyer K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD006745. PubMed ID: 25620061
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Involvement of heat shock protein 47 in Schistosoma japonicum-induced hepatic fibrosis in mice.
    Huang JQ; Tao R; Li L; Ma K; Xu L; Ai G; Fan XX; Jiao YT; Ning Q
    Int J Parasitol; 2014 Jan; 44(1):23-35. PubMed ID: 24295791
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and pai-1 mRNA transcription.
    Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
    J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Suppression of plasminogen activators and the MMP-2/-9 pathway by a Zanthoxylum avicennae extract to inhibit the HA22T human hepatocellular carcinoma cell migration and invasion effects in vitro and in vivo via phosphatase 2A activation.
    Dung TD; Feng CC; Kuo WW; Pai P; Chung LC; Chang SH; Hsu HH; Tsai FJ; Lin YM; Huang CY
    Biosci Biotechnol Biochem; 2013; 77(9):1814-21. PubMed ID: 24018669
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pathogenesis of FOLFOX induced sinusoidal obstruction syndrome in a murine chemotherapy model.
    Robinson SM; Mann J; Vasilaki A; Mathers J; Burt AD; Oakley F; White SA; Mann DA
    J Hepatol; 2013 Aug; 59(2):318-26. PubMed ID: 23624001
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.